Pushing The Boundaries In Stroke Innovation
Novel device to minimise Ischemic reperfusion injury post thrombectomy.

Our Mission
Cerefuze Medical is dedicated to creating innovative medical devices to minimize ischemic reperfusion injury post-thrombectomy. For inquiries or partnerships, please reach out to us. Your collaboration fuels our mission to improve patient outcomes.
WHAT IS REPERFUSION INJURY
UNMET CLINICAL NEED

Of those patients who undergo “successful” thrombectomy (76,000 Cases alone in the USA by 2028), unfortunately only approximately 46% achieve a positive outcome.
The remaining 54% do not attain good outcomes despite timely and complete recanalization. This poor outcome is linked to reperfusion injury.
The majority of stroke-related healthcare costs are driven by patients with poor outcomes, primarily due to long-term disability. This represents a significant market opportunity exceeding $20 billion in the United States alone.